16 funds hold it in their latest portfolios. Ranked by how much of each fund it is.
| Fund | Share of the fund | 1Y | 3Y, annualised | Expense | Size |
|---|---|---|---|---|---|
1.5% |
| — |
| — |
| 2.81% |
| ₹327 cr |
Abakkus Small Cap Fund Abakkus · Small Cap | 1.0% | — | — | 2.45% | ₹3,384 cr |
Nippon India Pharma Fund Nippon India · Sectoral / Thematic | 1.0% | +8.2% | +17.4% | 1.83% | ₹9,127 cr |
Sundaram Dividend Yield Fund Sundaram · Dividend Yield | 0.5% | -7.9% | +8.3% | 2.45% | ₹764 cr |
Aditya Birla Sun Life Balanced Advantage Fund Aditya Birla Sun Life · Balanced Advantage / Dynamic Asset Allocation | 0.4% | +2.9% | +10.8% | 1.95% | ₹9,937 cr |
Aditya Birla Sun Life Large Cap Fund Aditya Birla Sun Life · Large Cap | 0.4% | -6.2% | +9.6% | 1.69% | ₹28,479 cr |
Bandhan Flexi Cap Fund Bandhan · Flexi Cap | 0.2% | -3.3% | +10.8% | 2.19% | ₹7,247 cr |
Bandhan Multi Asset Allocation Fund Bandhan · Multi Asset Allocation | 0.2% | +4.4% | — | 2.16% | ₹3,645 cr |
Tata Ethical Fund Tata · Sectoral / Thematic | 0.2% | -7.9% | +4.5% | 1.97% | ₹3,740 cr |
Nippon India Small Cap Fund Nippon India · Small Cap | 0.2% | +0.8% | +12.2% | 1.41% | ₹77,995 cr |
Bandhan BSE Healthcare Index Fund Bandhan · Index | 0.2% | +11.5% | — | 1.14% | ₹21.3 cr |
Motilal Oswal BSE Healthcare ETF Motilal Oswal · Exchange Traded | 0.2% | +12.6% | +22.5% | 0.34% | ₹44.6 cr |
SBI Contra Fund SBI · Contra | 0.2% | -7.9% | +9.5% | 1.63% | ₹45,212 cr |
Nippon India Growth Mid Cap Fund Nippon India · Mid Cap | 0.1% | -0.4% | +15.6% | 1.56% | ₹49,505 cr |
Quant Small Cap Fund quant · Small Cap | 0.1% | +5.0% | +15.2% | 1.66% | ₹33,804 cr |
Motilal Oswal BSE 1000 Index Fund Motilal Oswal · Index | 0.0% | -5.5% | — | 1.11% | ₹60.5 cr |
16 funds hold it in their latest portfolios as of 30 Sept 2026. As a share of the fund, the most is in Bandhan Healthcare Fund (1.5%), Abakkus Small Cap Fund (1.0%) and Nippon India Pharma Fund (1.0%).
Nippon India Small Cap Fund (about ₹140 cr), Aditya Birla Sun Life Large Cap Fund (about ₹105 cr) and Nippon India Pharma Fund (about ₹91 cr), worked out from each fund's size and the share it holds.
NAV, expense ratio and fund disclosures as published by AMFI and the fund houses. Figures are computed independently and may differ from a fund house's own factsheet.
DiscoverMF is an information and analytics service. Nothing here is investment advice, a recommendation, or an offer to buy or sell any scheme. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past performance does not indicate future returns.